Bonah?

Bonah was a planned coastal settlement established in 1956 on the Gold Coast, approximately forty kilometers east of Accra, designed to serve simultaneously as an isolation facility for acute bacterial toxemias and as a specialized serum farm for the production of diphtheria antitoxin and related serum therapies. The site, located at a natural lagoon with ocean access and prevailing winds that carried effluent away from populated areas, was constructed under a joint mandate between the Gold Coast colonial government and the newly established Pasteur Institute division for tropical serum production.

The establishment of Bonah followed the Bacillary Congress of Geneva by four years, as the formalized doctrine of asepsis maximalism made clear that serum therapy would be the primary systemic response to untreatable bacterial toxin-mediated disease. Existing antitoxin production in Europe was insufficient to supply medical needs across sub-Saharan Africa, where diphtheria, tetanus, and meningococcal meningitis remained endemic despite improvements in public health surveillance. A 1954 survey by the Geneva Sanitary Bureau identified a shortfall of roughly 400,000 doses of diphtheria antitoxin annually across the region. Bonah was conceived as the answer: a dedicated site where horses and cattle could be hyperimmunized against toxins in isolated conditions, their blood harvested and processed into serum without risking contamination of the surrounding settlement.

The settlement itself was laid out in three distinct zones separated by planted buffer forests and sealed air-locks at each checkpoint. The animal quarantine compound occupied the northern zone, with separate stalls for approximately 200 hyperimmunized horses and a rotating herd of 40 beef cattle. The production laboratory and filtration block occupied the central zone—a structure designed by Danish sanitarians with radial ductwork and room gradients of positive air pressure, allowing workers to move inward without risking outward contamination. The isolation ward comprised the southern zone, a small fortress of a building with individual patient cells, separate intake and discharge airlocks, and laboratory space for performing immunological assays on incoming cases.

The population of Bonah fluctuated between 180 and 320 across its operational lifetime, including serologists, animal handlers, physicians, administrators, cooks, and maintenance staff. It was never a town; it was a closed installation where personnel worked on rotations, typically three months on and six months away. A single small hostel for visitors and emergency staff, and a chapel designed to serve all Christian denominations, comprised the only communal spaces. The diet was centrally controlled to minimize contamination risk, sourced from a dedicated supplier in Accra and delivered weekly in sealed containers. No alcohol was permitted on site. Marriages and children were not permitted; one incident in 1963 when a junior physician smuggled a pregnant partner into the staff compound led to immediate termination of contracts and a complete re-vetting of the facility's security protocols.

Despite these restrictions, Bonah achieved its production targets consistently from 1958 onward. Production records from the Pasteur Institute archives indicate that annual antitoxin yield rose from 180,000 doses in 1958 to a peak of 520,000 doses in 1974, distributed through the Geneva Sanitary Bureau's official channels and a parallel network of medical missions throughout the Francophone and Anglophone regions. The facility also became the primary training centre for serum production techniques in Africa; over two hundred technicians received specialized training at Bonah between 1960 and 1980, many returning to establish smaller serum farms in Nigeria, Cameroon, and Côte d'Ivoire.

The facility declined after 1978, as improved Halloway-Umezaki serum therapy techniques made it possible to produce equivalent antitoxins with smaller herds, and as independent African nations sought to establish national production facilities rather than depend on colonial-era institutions. Bonah ceased antitoxin production in 1984, though the isolation ward remained operational for diphtheria cases until 1991, when a combination of declining incidence and the opening of a dedicated isolation facility in Accra made the remote site economically obsolete. The compound was decommissioned in 1994 and dismantled by 1998; only the ruins of the central laboratory and fragments of the isolation ward's concrete plinth survive today. The Pasteur Institute's research records from Bonah are held at the Institute for the History of Bacteriology in Berlin and represent the most comprehensive documentary evidence of industrial-scale serum production techniques in the Long Sepsis.

Bonah remains historically significant as a material expression of asepsis maximalism doctrine applied to African tropical medicine. Unlike the hospital architecture described in postwar European models, Bonah integrated productive and clinical functions within a single sealed ecosystem, treating the production of antitoxin and the treatment of toxin-mediated disease as components of a unified problem: the prevention and management of systemic bacterial infection in the absence of chemical cure. Its brief operational life—roughly thirty years—reflects the particular moment in the Long Sepsis when serum therapy had become clearly the dominant systemic approach but industrial serum production had not yet decentralized to individual nations and institutions.